As a regulator, I can tell you that the large difference between manufacturing cost and MRP for unbranded medicines was often due to massive trade margins and supply chain inefficiencies, which exploited the patient's lack of choice. The Jan Aushadhi scheme fixes this by procuring generics directly from manufacturers and selling them through dedicated stores with a minimal retailer margin, often bringing prices down by 50-90%. This isn't just policy to me; I remember buying a month's blood pressure medication for my late husband from a Jan Aushadhi outlet for less than the auto fare to the big pharmacy, and the relief was both financial and deeply human.
#health#hospitals
Jump in to reply — no account needed.